# Litaizhiyao

AI-native peptide drug research and development platform.



Canonical: https://uniquebase.ai/companies/UB-C9166
Stable identifier: UB-C9166
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T19:41:54.989Z

## Funding

Listed 1 record.
Latest: nearly RMB 50M (Seed), 2026-10-10.

- 2026-10-10 · nearly RMB 50M (≈ $7.14M) · Seed · L2F, 知名产业方, 讯飞创投 · https://36kr.com/newsflashes/4021094815960969
  > On October 10, 2026, per 36Kr, AI-native peptide drug discovery platform Litai Zhiyao completed a near-¥50M seed round co-invested by iFlytek Ventures, L2F Fund and an unnamed industrial investor, for pipeline R&D, compute and patents. (translated source brief)

## Valuation

Listed 1 record.

- 2026-10-10 · amount unavailable · Seed · L2F, 知名产业方, 讯飞创投 · https://36kr.com/newsflashes/4021094815960969
  > On October 10, 2026, per 36Kr, AI-native peptide drug discovery platform Litai Zhiyao completed a near-¥50M seed round co-invested by iFlytek Ventures, L2F Fund and an unnamed industrial investor, for pipeline R&D, compute and patents. (translated source brief)

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

- [Litaizhiyao](/products/li-tai-zhi-yao)

## Investors

- [L2F](/institutions/guangyuan-l2f-fund)
- [知名产业方](/institutions/zhiming-industry-fang)
- [讯飞创投](/institutions/xunfei-venture-capital)

## Sources

- No source links are available for this profile.